Comparison between Aptus Pharma IPO and Nikita Papers IPO.
Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Nikita Papers IPO is a SME Bookbuilding proposed to list at NSE SME.
| Aptus Pharma IPO | Nikita Papers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Fast Track Finsec Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Aptus Pharma IPO is up to ₹0.00 Cr whereas the issue size of the Nikita Papers IPO is up to ₹64.15 Cr. The final issue price of Aptus Pharma IPO is and of Nikita Papers IPO is ₹104.00 per share.
| Aptus Pharma IPO | Nikita Papers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹95.00 per share | |
| Issue Price (Upper) | ₹104.00 per share | |
| Issue Price (Final) | ₹104.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | |
| Fresh Issue Size | 20,00,000 shares | 61,68,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹64.15 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 20,00,000 shares | 61,68,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹64.15 Cr |
Aptus Pharma IPO opens on , while Nikita Papers IPO opens on May 27, 2025. The closing date of Aptus Pharma IPO and Nikita Papers IPO is , and May 29, 2025, respectively.
| Aptus Pharma IPO | Nikita Papers IPO | |
|---|---|---|
| Anchor Bid Date | May 26, 2025 | |
| Issue Open | May 27, 2025 | |
| Issue Close | May 29, 2025 | |
| Basis Of Allotment (Tentative) | May 30, 2025 | |
| Initiation of Refunds (Tentative) | Jun 02, 2025 | |
| Credit of Share (Tentative) | Jun 02, 2025 | |
| Listing date (Tentative) | Jun 03, 2025 | |
| Anchor Lockin End date 1 | Jun 30, 2025 | |
| Anchor Lockin End date 2 | Aug 28, 2025 |
Aptus Pharma IPO P/E ratio is , as compared to Nikita Papers IPO P/E ratio of 11.39.
| Aptus Pharma IPO | Nikita Papers IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Aptus Pharma Limited Financial Information (Restated)Aptus Pharma Limited's revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Nikita Papers Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 80.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.219 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹256.55 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.45% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 28.71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.45% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aptus Pharma IPO Retail Individual Investors (RII) are offered while in Nikita Papers IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Aptus Pharma IPO and 22,15,200 shares in Nikita Papers IPO.
| Aptus Pharma IPO | Nikita Papers IPO | |
|---|---|---|
| Anchor Investor Reserveration | 8,68,800 shares | |
| Market Maker Reserveration | 3,26,400 shares | |
| QIB | 22,15,200 shares | |
| NII | 9,25,200 shares | |
| RII | 21,58,800 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 61,68,000 shares |
Aptus Pharma IPO subscribed in total, whereas Nikita Papers IPO subscribed 1.43x.
| Aptus Pharma IPO | Nikita Papers IPO | |
|---|---|---|
| QIB (times) | 0.74x | |
| NII (times) | 2.11x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.84x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.43x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
